Bisphosphonate Associated Atypical Femoral Fractures
Michael Maricic, M.D.
Catalina Pointe Rheumatology
1) Recognize the Major and Minor criteria for Atypical Femoral Fractures
2) Assess the incidence rates of bisphosphonate associated atypical femoral fractures
3) Discuss the diagnostic work up needed for patients with these fractures
Disclosure: Grant/Research Support/Consultant/Speakers Bureau: Amgen, Lilly, Merck, Novartis, Proctor & Gamble.